Table 3

Relation between complete regression (CR) of mucosa associated lymphoid tissue lymphoma after eradication and pretreatment clinicopathological factors

Factor	No of CR/ all patients	No of CR by 12 M^3-151	Probability of CR at 12 M^3-152	p Value^3-150
Depth of invasion by EUS
Mucosa	26/28	23/26	0.85	0.015
sm or beyond	3/13	3/12	0.45
Modified Ann Arbor stage
EI₁	25/30	23/27	0.87	0.0502
EI₂/EII	4/11	3/11	0.55
Endoscopic appearance
SS type	26/32	23/29	0.83	0.085
Other types	3/9	3/9	0.56
H pyloridensity^3-154
Many (3/2)	23/30	21/28	0.86	0.080
Few (1/0)	6/11	5/10	0.61
High grade component
Yes	5/10	5/10	1.00	0.908
No	24/31	21/28	0.77
Perigastric lymphadenopathy
Yes	3/5	2/5	0.60	0.736
No	26/36	24/33	0.82
Dominant site of lesion
Fundus/corpus	23/34	21/31	0.79	0.721
Antrum	6/7	5/7	0.83

M, month; sm, submucosa; SS, superficial spreading.
↵3-151 Subjects with partial regression who had been observed for less than 12 months were excluded.
↵3-152 Kaplan-Meier analysis.
↵3-150 Log rank test.
↵3-154 Updated Sydney system.